Agilent Technologies (A) stock
Last close $170.38 on 2026-11-20 (-2.83%) · Sector: Healthcare
Agilent Technologies is a healthcare company that makes scientific instruments, software, and services. Its customers include laboratories, drug researchers, and clinical testing sites that use its tools to analyze samples and run complex tests. It earns money mainly by selling these instruments and by providing ongoing service, consumables, and support contracts.
Agilent's sales are growing modestly, with trailing revenue up 8.5% and its latest quarter bringing in about $1.9 billion. Over the past year the stock returned 12.6%, beating the S&P 500's 4.67% return, though it swings more than the overall market. The shares are trading about 6.9% below their 52-week high and sit well above their 200-day average. Insiders have sold shares recently, including a director's sale in September 2026, and the stock rose the day after three of its four most recent earnings releases.
Key numbers
- Market cap: $48.2B
- Revenue (last 12 months): $7.37B
- Revenue growth: +8.5%
- Gross margin: 53.8%
- Operating margin: 22.1%
- P/E: 33.5
- P/S: 6.5
- Debt to equity: 0.50
- Current ratio: 2.05
Quality score
Overall 35/100 · growth 37 · profitability 47 · financial health 56 · value 0
Performance and risk
1-year return +12.6% vs S&P 500 +4.7% · volatility 33.0% (S&P 500 14.3%) · largest drop -29.9% · beta 0.86
Stock move the day after earnings
- 2025-11-24: +2.3%
- 2026-02-25: -3.0%
- 2026-05-27: +16.9%
- 2026-08-26: +1.7%
Insider trades (12 months)
Bought $0.0M · sold $1.2M
A stock research · A options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.